ESC 365 - Inferior vena cava and lung ultrasound-guided therapy in acute heart failure (CAVAL US-AHF study): a randomized controlled trial

ESC Professional Premium Access

Inferior vena cava and lung ultrasound-guided therapy in acute heart failure (CAVAL US-AHF study): a randomized controlled trial

Session: Acute heart failure: prevention and treatment

Topic: Treatment

Speaker: Ms L. Burgos (Buenos Aires, AR)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Ms Lucrecia Maria Burgos

Instituto Cardiovascular De Buenos Aires, Buenos Aires (Argentina)

0 follower

7 more presentations in this session

A 7-year longitudinal association of total cholesterol with premature structural and functional cardiac damage progression in youth: the ALSPAC birth cohort study

Speaker: Doctor A. Agbaje (Kuopio, FI)

Cumulative accelerometer-based light physical activity from childhood through young adulthood progressively decreases left ventricular mass in British youth: a 13-year longitudinal study

Speaker: Doctor A. Agbaje (Kuopio, FI)

Association between obstructive sleep apnea and heart failure in patients with and without obesity: a population-based cohort study

Speaker: Mr K. Kim (Goyang, KR)

Validating the association between a composite metric of guideline-directed medical therapy (GDMT) and clinical outcomes for patients with heart failure with reduced ejection fraction (HFrEF)

Speaker: Ms J. Calma (Palo Alto, US)

Early versus delayed introduction of renin angiotensin aldosterone system inhibitors in cardiogenic shock

Speaker: Assistant Professor M. Zeitouni (Paris, FR)

Access the full session

Acute heart failure: prevention and treatment

Speakers: Ms L. Burgos, Doctor A. Agbaje, Doctor A. Agbaje, Mr K. Kim, Ms J. Calma...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by